Medical - Diagnostics & Research industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
86 of 152
P/E 36.6 vs period average 32.6 Richer than its history
Ranked among 30 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/30 | ![]() | $70.53 | 34.1 | 48 | 74 | 93 | 98 |
| 2/30 | ![]() | $242.56 | 24.2 | 95 | 62 | 64 | 95 |
| 3/30 | ![]() | $331.17 | 27.4 | 97 | 69 | 54 | 90 |
| 4/30 | ![]() | $50.28 | 35.9 | 57 | 89 | 92 | 89 |
| 5/30 | ![]() | $271.55 | 33.0 | 93 | 48 | 76 | 87 |
| 6/30 | ![]() | $673.79 | 37.3 | 51 | 75 | 90 | 84 |
| 7/30 | ![]() | $177.49 | 34.9 | 59 | 21 | 75 | 82 |
| 8/30 | ![]() | $161.86 | 77.1 | 56 | 23 | 78 | 80 |
| 9/30 | ![]() | $50.17 | 26.1 | 85 | 15 | 47 | 79 |
| 10/30 | ![]() | $279.47 | 52.0 | 25 | 10 | 100 | 77 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $11B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $22B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $4B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.1% | $47B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks